Search

Your search keyword '"Mann, Graham"' showing total 234 results

Search Constraints

Start Over You searched for: Author "Mann, Graham" Remove constraint Author: "Mann, Graham" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
234 results on '"Mann, Graham"'

Search Results

2. The landscape of genomic structural variation in Indigenous Australians

3. Uncovering the complex relationship between balding, testosterone and skin cancers in men

4. Cancer Risks Associated With TP53 Pathogenic Variants: Maximum Likelihood Analysis of Extended Pedigrees for Diagnosis of First Cancers Beyond the Li-Fraumeni Syndrome Spectrum

5. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia

6. The impact of coding germline variants on contralateral breast cancer risk and survival

7. The Recovery and Re-Calibration of a 13-Month Aerosol Extinction Profiles Dataset from Searchlight Observations from New Mexico, after the 1963 Agung Eruption

8. Analysis of the global atmospheric background sulfur budget in a multi-model framework

9. Anatomic position determines oncogenic specificity in melanoma

12. Impact of personal genomic risk information on melanoma prevention behaviors and psychological outcomes: a randomized controlled trial

13. The 2019 Raikoke eruption as a testbed used by the Volcano Response group for rapid assessment of volcanic atmospheric impacts.

14. Antarctic vortex dehydration in 2023 as a substantial removal pathway for Hunga Tonga-Hunga Ha'apai water vapour

16. Acceptability and appropriateness of a risk-tailored organised melanoma screening program: Qualitative interviews with key informants

17. Follow-up assessment of sleep-related symptoms in patients after treatment for cancer: responses to continuous positive airway pressure treatment for co-morbid obstructive sleep apnoea

18. Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling

19. Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

20. Antarctic Vortex Dehydration in 2023 as a Substantial Removal Pathway for Hunga Tonga‐Hunga Ha'apai Water Vapor.

22. ACEMID cohort study: protocol of a prospective cohort study using 3D total body photography for melanoma imaging and diagnosis

23. Analysis of the global atmospheric background sulfur budget in a multi-model framework

24. The association of dermatologist demographic density with melanoma survival in New South Wales, Australia

25. Perspectives of health professionals and patients on implementation of a predictive model of response to immunotherapies in advanced melanoma

26. The 2019 Raikoke eruption as a testbed for rapid assessment of volcanic atmospheric impacts by the Volcano Response group

27. Data from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas

28. Supplementary Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes

29. Supplementary Figure Legends from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas

30. Data from Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes

31. Supplementary Figures and Tables from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas

33. Supplementary Table 1 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma

34. Supplementary Table 2 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma

35. Data from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma

37. Data from Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma

38. Supplementary Table 3 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma

39. Supplementary Data from Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma

41. Supplementary Table 4 from A High-Throughput Panel for Identifying Clinically Relevant Mutation Profiles in Melanoma

45. Data from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults

46. Supplementary Figure Legend from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

47. Figure S5 from PD-L1 Negative Status is Associated with Lower Mutation Burden, Differential Expression of Immune-Related Genes, and Worse Survival in Stage III Melanoma

48. Supplementary materials (clean version) from A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public

49. Supplementary Figure S1 from Accuracy of Self-Reported Nevus and Pigmentation Phenotype Compared with Clinical Assessment in a Population-Based Study of Young Australian Adults

50. Supplementary Table 2 from BRAF/NRAS Wild-Type Melanomas Have a High Mutation Load Correlating with Histologic and Molecular Signatures of UV Damage

Catalog

Books, media, physical & digital resources